ACCL2031
OPEN TO ACCRUAL
Ph3 randomized,placebo controlled trial with Mematine for Neurocognitive Protection
ACNS1833
OPEN TO ACCRUAL
Phase 3 Rand Selumetinib vs. Carbo/Vinc in Newly Dx or Previously Untreated Non-BRAFV600E andNF1 LGG
ACNS2021
OPEN TO ACCRUAL
Phase 2 Chemo followed by WVSC Irradiation for patients with NGGCT
APEC1621SC
OPEN TO ACCRUAL
APEC1621_Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
UW16123
OPEN TO ACCRUAL
UW16123, HEADSTART 4
UW23096
OPEN TO ACCRUAL
Study of CLR131 in Children/AYA with Brain Tumors (Part B)